Lipella Pharmaceuticals Inc (LIPO)
NASDAQ
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -12.984 | -125.674 | -65.252 | -96.967 |
Return on Equity (%) | -26.782 | -197.668 | -85.18 | -118.133 |
Return on Invested Capital (%) | -22.222 | -192.854 | -84.228 | -121.381 |
Operating Margin (%) | -5.613 | -717.375 | -1406.522 | -1024 |
Net Profit Margin (%) | -6.445 | -720.077 | -1411.957 | -1026.444 |
Book Value Per Share | 0.081 | 0.147 | 0.484 | 0.542 |
Earnings Per Share | -0.011 | -0.193 | -0.269 | -0.796 |
Cash Per Share | 0.106 | 0.146 | 0.53 | 0.568 |
Working Capital Per Share | 0.086 | 0.152 | 0.478 | 0.524 |
Operating Profit Per Share | 0.168 | 0.027 | 0.019 | 0.078 |
EBIT Per Share | -0.011 | -0.193 | -0.269 | -0.796 |
EBITDA Per Share | -0.011 | -0.193 | -0.269 | -0.796 |
Free Cash Flow Per Share | -0.011 | -0.193 | -0.269 | -0.794 |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Shares Outstanding | 5.74M | 9.67M | N/A | N/A |
Year End December 30 2023 | Mar 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||||
Shares Outstanding | 9.67M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -2230.303 | -900.847 | N/A | N/A | N/A | -816.438 | N/A |
Net Profit Margin (%) | -2236.364 | -905.085 | N/A | N/A | N/A | -816.438 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 3.1M |
Price to Earnings Ratio | -0.68 |
Price to Sales Ratio | 6.94 |
Price to Cash Ratio | 0.95 |
Price to Book Ratio | 0.99 |
Dividend Yield | - |
Shares Outstanding | 8M |
Average Volume (1 week) | 245.06k |
Average Volume (1 Month) | 2.15M |
52 Week Change | -66.77% |
52 Week High | 1.50 |
52 Week Low | 0.3234 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.